Surya P Bhatt
University of Alabama at Birmingham
H-index: 47
North America-United States
Top articles of Surya P Bhatt
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Characteristics of Virtual Pulmonary Rehabilitation Programs in the US: Results From a National Electronic Survey | CM Garvey SP Bhatt J Corn A Kizziar R Kaye | 2024/5 | |
Inhaling Danger: Air Pollution Fuels Progressive Pulmonary Fibrosis | JL Larson-Casey K Saleem R Surolia J Pandey M Mack | 2024/5 | |
Type 2 Inflammation Is Associated With CT Emphysema | SP Bhatt A Nakhmani S Bodduluri | 2024/5 | |
CT-based Vascular Surface Area-to-Volume Ratio as an Imaging Marker to Phenotype Subjects With Predominant Vascular Loss Versus Narrowing in COPD | V Sthanam S Bodduluri JM Reinhardt A Nakhmani SP Bhatt | 2024/5 | |
Dupilumab Improves Pre-bronchodilator Lung Function Measures in Patients With Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation: Data From the Phase 3 … | A Papi NA Hanania SP Bhatt KF Rabe CF Vogelmeier | 2024/5 | |
Bronchio: A Zero-shot Learning-based Tool for Pulmonary Airway Analyses | V Wu V Sthanam A Pudhota A Nakhmani MFA Chaudhary | 2024/5 | |
Early evidence of chronic obstructive pulmonary disease obscured by race-specific prediction equations | American journal of respiratory and critical care medicine | Elizabeth A Regan Melissa E Lowe Barry J Make Jeffrey L Curtis Quan Chen | 2024/1/1 |
Dysanapsis is differentially related to lung function trajectories with distinct structural and functional patterns in COPD and variable risk for adverse outcomes | Eclinicalmedicine | James C Ross Raul San José Estépar Sam Ash Carrie Pistenmaa MeiLan Han | 2024/2/1 |
Correction: Myeloid Heterogeneity Mediates Acute Exacerbations of Pulmonary Fibrosis | The Journal of Immunology | Jennifer L Larson-Casey Komal Saleem Ranu Surolia Jyotsana Pandey Matthias Mack | 2024/2/26 |
A 3-year Descriptive Assessment of Exacerbations and Double/Triple Inhaler Use Among Chronic Obstructive Pulmonary Disease (COPD) Patients in the United States (US) | SP Bhatt Y Zhang J White R Halpern RH Stanford | 2024/5 | |
Tracheal Lumen Eccentricity Is Associated With Respiratory Morbidity and Mortality in COPD | SM Aguilera V Sthanam A Nakhmani JM Reinhardt SP Bhatt | 2024/5 | |
Impact of Race-neutral Spirometry Reference Equations on Eligibility for Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials | CM Karoleski S Rajan CA Rapoza J Radder W Slivka | 2024/5 | |
Artificial Intelligence Models in the Detection of Patient Ventilator Asynchrony: A Review of Techniques and Clinical Targets | A Tlimat C Fowler S Bodduluri SP Bhatt PE Morris | 2024/5 | |
Dupilumab Does Not Impact Blood Eosinophil Levels in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: From the Phase 3 Boreas Trial | M Bafadhel SA Christenson NA Hanania SP Bhatt KF Rabe | 2024/5 | |
Screening for Type 2 Inflammation and High Exacerbation Endophenotype in COPD | S Bodduluri A Nakhmani SP Bhatt | 2024/5 | |
Lung structure and risk of Sleep apnea in SPIROMICS | Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation | Abigail L Koch Tracie L Shing Andrew Namen David Couper Benjamin Smith | 2024 |
Reply to Neder, to Ogata et al., and to Graham | American journal of respiratory and critical care medicine | Surya P Bhatt Arie Nakhmani Spyridon Fortis Matthew J Strand Edwin K Silverman | 2024/2/1 |
Early Diagnosis and Treatment of COPD: The Costs and Benefits of Case-Finding | American Journal of Respiratory and Critical Care Medicine | Shawn D Aaron Maria Montes de Oca Bartolome Celli Surya P Bhatt Jean Bourbeau | 2024/2/15 |
Ensifentrine, A Novel, Selective Inhibitor of PDE3 and PDE4, Improved Dyspnea in Subjects With Symptomatic, Moderate-to-Severe COPD Over 24 Weeks | FC Sciurba S Christenson T Rheault D Reyner T Bengtsson | 2024/5 | |
COPDxNet: An End-to-End Deep Neural Network for COPD Detection | ASA Rabby P Saha A Nakhmani JM Reinhardt C Zhang | 2024/5 |
